Evidence map›Paper›PMID 40336767›Full record

ArticleInternational journal of applied & basic medical research

Effect of

Jinay Paresh Mehta, Urmila Anil Kagal, Prakash R Biradar

Abstract read
In one paragraph

Article in International journal of applied & basic medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinay Paresh MehtaDepartment of Pharmacology, KLE Academy of Higher Education and Research, Deemed-to-be-University, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.
Urmila Anil KagalDepartment of Pharmacology, KLE Academy of Higher Education and Research, Deemed-to-be-University, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.
Prakash R BiradarDepartment of Pharmacology, KLE Academy of Higher Education and Research, Deemed-to-be-University, KLE College of Pharmacy, Belagavi, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Depression affects millions globally, with existing treatments having many side effects. Aim: This study evaluated the effect of WS alone and in combination with fluoxetine on neuritin, NARP, and BDNF Exon-III gene expression in the hippocampus of male Wistar rats subjected to chronic unpredictable mild stress (CUMS). Materials and Methods: Thirty male Wistar rats were divided into five groups ( Results: After 7 weeks, the ST, WS, and FW groups showed a significant increase in sucrose preference compared to the DC group. The ST and FW groups showed significant upregulation of all three genes selected in the present study. Comparison between NG and FW groups showed no significant difference in gene expression. Conclusion: This study highlights the antidepressant effects of WS by demonstrating its effect on BDNF-associated gene expression. Fluoxetine combined with WS demonstrated additive effects which proves an adjuvant role of WS in the treatment of depression. Further studies involving human subjects are essential to validate the antidepressant effects of WS and its additive effects with fluoxetine.

Indexed as

Brain-derived neurotrophic factor exon-IIIdepressionfluoxetinegene expressionNARPneuritinWithania somnifera

Identifiers

PMID40336767
PMCPMC12054648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.